Diclofenacdrug info
diclofenac potassium 50 MG Powder for Oral Solution
What it is used for
Diclofenac potassium for oral solution is indicated for the acute treatment of migraine attacks with or without aura in adults (18 years of age or older).
Limitations of Use: Diclofenac potassium for oral solution is not indicated for the prophylactic therapy of migraine. The safety and effectiveness of diclofenac potassium for oral solution have not been established for cluster headache, which is present in an older, predominantly male population. Diclofenac potassium for oral solution is a non-steroidal anti-inflammatory drug (NSAID) indicated for the acute treatment of migraine attacks with or without aura in adults 18 years of age or older Limitations of Use: Diclofenac potassium for oral solution is not indicated for the prophylactic therapy of migraine Safety and effectiveness of diclofenac potassium for oral solution not established for cluster headache, which is present in an older, predominantly male population
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective July 16, 2026. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
Description
Diclofenac potassium for oral solution, USP is a nonsteroidal anti-inflammatory drug, available as a flavored powder, designed to be mixed with water prior to oral administration. Diclofenac potassium for oral solution, USP is a white to off-white, flavored powder for oral solution packaged in individual unit dose packets. The chemical name is 2-[(2,6-dichlorophenyl)amino] benzeneacetic acid monopotassium salt. The molecular weight is 334.25. Its molecular formula is C 14 H 10 Cl 2 NKO 2, and it has the following structure. The inactive ingredients in diclofenac potassium for oral solution, USP include: aspartame (equivalent to 22.45 mg phenylalanine), glyceryl behenate, mannitol, peppermint flavor, polacrilin potassium, and saccharin sodium. structure
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective July 16, 2026. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
This page reproduces regulatory text for reference. It is not medical advice, and KenyRx is not a pharmacy or a prescriber. Talk to a doctor or pharmacist about whether a medicine is right for you.
See what it costs — price without insurance